soul trial oral semaglutide cardiovascular outcomes 2024 Frontiers Oral semaglutide (14 mg) demonstrates

A sandwich strategy for functional cure of chronic hepatitis B

doi: 10.1016/S0149-7634(05)80149-6

Key Takeaways CJC-1295 is an injectable peptide that raises GH, which some people claim can improve body composition and sleep and slow down aging

10.1124/jpet.105.083386 157 LiX.HuaS.ZhongD.ZhouM.DingZ

In clinical trials, Januvia proved effective in controlling blood sugar levels, but some studies reported rare and serious side effects, including acute pancreatitis, severe joint pain and, possibly, pancreatic cancer

The landmark SURMOUNT-1 trial demonstrated average weight loss of approximately 20% of body weight over 72 weeks at the highest dose greater than any single-receptor GLP-1 drug